Earnings summaries and quarterly performance for Alignment Healthcare.
Executive leadership at Alignment Healthcare.
John Kao
Detailed
Chief Executive Officer
CEO
AW
Andreas Wagner
Detailed
Chief Human Resources Officer
CJ
Christopher Joyce
Detailed
Chief Legal & Administrative Officer
DM
Dawn Maroney
Detailed
President
JH
Jim Head
Detailed
Chief Financial Officer
KK
Ken Kim
Detailed
Chief Medical Officer
RS
Robert Scavo
Detailed
Chief Information Officer
SB
Sebastian Burzacchi
Detailed
Chief Operating Officer – Management Services Organization
Board of directors at Alignment Healthcare.
Research analysts who have asked questions during Alignment Healthcare earnings calls.
Jessica Tassan
Piper Sandler
6 questions for ALHC
Also covers: ACCD, AMWL, CMAX +12 more
Michael Ha
Robert W. Baird & Co.
6 questions for ALHC
Also covers: AGL, ASTH, CNC +7 more
JR
John Ransom
Raymond James
5 questions for ALHC
Also covers: ACHC, ADUS, AMED +11 more
MG
Matthew Gillmor
KeyCorp
5 questions for ALHC
Also covers: ACHC, ADUS, ARDT +12 more
Whit Mayo
Leerink Partners
5 questions for ALHC
Also covers: ACHC, AHCO, AMED +12 more
Andrew Mok
Barclays
4 questions for ALHC
Also covers: ACHC, ADUS, AGL +21 more
CJ
Craig Jones
Stifel Financial Corp.
4 questions for ALHC
Also covers: AGL, ASTH, OSCR +1 more
JY
Jonathan Yong
UBS
4 questions for ALHC
Also covers: CLOV, EHTH, OSCR
RL
Ryan Langston
TD Cowen
4 questions for ALHC
Also covers: ACHC, ADUS, AGL +15 more
JS
John Stansel
JPMorgan Chase & Co.
3 questions for ALHC
Also covers: ACH, CAH, CNC +5 more
Adam Ron
Bank of America Corporation
2 questions for ALHC
Also covers: AGL, CI, CNC +3 more
Raj Kumar
Stephens
2 questions for ALHC
Also covers: ACHC, ADUS, ARDT +11 more
RD
Ryan Daniels
William Blair & Company, L.L.C.
2 questions for ALHC
Also covers: ACCD, AGL, DOCS +12 more
SB
Sam Beckeron
Goldman Sachs
2 questions for ALHC
Also covers: OSCR, UHS
TY
Tiffany Yuan
Barclays
2 questions for ALHC
JH
Jared Haase
William Blair & Company
1 question for ALHC
Also covers: ADUS, BTSG, DH +11 more
JG
Joanna Gajuk
Bank of America
1 question for ALHC
Also covers: ACHC, ADC, ADUS +22 more
MG
Matthew Gilmore
KeyBanc Capital Markets
1 question for ALHC
Also covers: ACHC, ASTH, EVH +5 more
SF
Scott Fidel
Stephens Inc.
1 question for ALHC
Also covers: ACHC, ADUS, AMED +17 more
Recent press releases and 8-K filings for ALHC.
Alignment Healthcare Announces Secondary Offering of Common Stock
ALHC
- Alignment Healthcare, Inc. entered into an underwriting agreement on March 2, 2026, for the sale of 13,167,733 shares of its common stock.
- The shares were offered by a selling stockholder, General Atlantic (ALN HLTH), L.P., and sold to underwriters, including J.P. Morgan Securities LLC.
- The closing of the offering and delivery of the shares took place on March 4, 2026.
- The Company will not receive any proceeds from the sale of these shares.
- The purchase price per share for the selling stockholders was $19.395.
9 hours ago
Alignment Healthcare Announces Pricing of Secondary Offering
ALHC
- Alignment Healthcare announced the pricing of an underwritten public offering of 13,167,733 shares of its common stock.
- The shares were sold by an affiliate of General Atlantic, L.P. (the Selling Stockholder) at a public offering price of $19.46 per share.
- Alignment Healthcare will not receive any of the proceeds from the sale of these shares.
- The offering is expected to close on March 4, 2026.
2 days ago
Alignment Healthcare Announces Secondary Offering
ALHC
- Alignment Healthcare, Inc. announced the commencement of an underwritten public offering of 13,167,733 shares of its common stock.
- The shares are being offered by an affiliate of General Atlantic, L.P., identified as the Selling Stockholder.
- Alignment Healthcare will not receive any of the proceeds from the sale of these shares.
- J.P. Morgan is acting as the underwriter for the proposed offering.
2 days ago
Alignment Healthcare Reports Strong Q4 and Full-Year 2025 Results, Provides Upbeat 2026 Guidance
ALHC
Earnings
Guidance Update
Revenue Acceleration/Inflection
- Alignment Healthcare reported Q4 2025 total revenue of $1 billion, a 44% year-over-year increase, and full-year 2025 total revenue of $3.9 billion, up 46% year-over-year.
- The company achieved full-year 2025 Adjusted EBITDA of $110 million, a significant improvement from approximately $1 million in 2024, representing a 2.8% adjusted EBITDA margin and 270 basis points of margin expansion.
- For full-year 2026, Alignment Healthcare projects health plan membership between 292,000 and 298,000 members and revenue between $5.14 billion and $5.19 billion.
- Adjusted EBITDA guidance for full-year 2026 is set at $133 million to $163 million, with Q1 2026 Adjusted EBITDA expected between $26 million and $36 million.
- The company ended 2025 with $604 million in cash and investments and secured a $200 million revolving credit facility subsequent to the quarter.
6 days ago
Alignment Healthcare Reports Strong Q4 and Full-Year 2025 Results, Provides Optimistic 2026 Guidance
ALHC
Earnings
Guidance Update
Revenue Acceleration/Inflection
- Alignment Healthcare reported Q4 2025 total revenue of $1 billion, a 44% year-over-year increase, and full-year 2025 total revenue of $3.9 billion, up 46% year-over-year.
- The company achieved full-year 2025 adjusted EBITDA of $110 million, a significant improvement from $1 million in 2024, representing an adjusted EBITDA margin of 2.8%.
- Health plan membership reached 236,300 in Q4 2025, growing 25% year-over-year, and further increased to 275,300 in January 2026, marking 31% year-over-year growth.
- For full-year 2026, ALHC provided guidance including revenue between $5.14 billion and $5.19 billion and adjusted EBITDA between $133 million and $163 million.
- The company highlighted its strong clinically led model, with 100% of members and plans rated 4 stars or above for 2027, enabling it to navigate industry changes and expand margins.
6 days ago
Alignment Healthcare Reports Strong Q4 and Full-Year 2025 Results, Issues Upbeat 2026 Guidance
ALHC
Earnings
Guidance Update
Revenue Acceleration/Inflection
- Alignment Healthcare achieved $3.9 billion in total revenue for full-year 2025, a 46% year-over-year increase, and significantly improved profitability with adjusted EBITDA of $110 million, up from $1 million in 2024.
- The company's health plan membership reached 275,300 in January 2026, representing 31% year-over-year growth, and it issued full-year 2026 guidance projecting revenue between $5.14 billion and $5.19 billion and adjusted EBITDA between $133 million and $163 million.
- Alignment Healthcare demonstrated strong expansion outside California, with ex-California membership more than doubling in 2025 and growing over 80% in January 2026, and strengthened its financial position by closing a $200 million revolving credit facility and ending 2025 with $604 million in cash and investments.
6 days ago
Alignment Healthcare Reports Strong Q4 and Full-Year 2025 Results, Raises 2026 Guidance
ALHC
Earnings
Guidance Update
Revenue Acceleration/Inflection
- Alignment Healthcare reported full-year 2025 revenue of $3.95 billion, a 46.1% growth year-over-year, and Q4 2025 total revenue of $1,012.8 million, up 44.4% year-over-year, exceeding the high-end of guidance across all key metrics.
- For full-year 2025, the company achieved Adjusted EBITDA of $109.9 million and a net loss of $1.0 million. In Q4 2025, Adjusted EBITDA was $11.4 million and net loss was $11.0 million.
- The company provided 2026 revenue guidance of $5.14 billion to $5.19 billion, representing 30%-31% growth year-over-year, and adjusted EBITDA guidance of $133 million to $163 million. Health plan membership guidance was also raised by 2,000 at the midpoint.
6 days ago
Alignment Healthcare Discusses Strong Growth, Differentiated Model, and Future Expansion at J.P. Morgan Conference
ALHC
Guidance Update
Revenue Acceleration/Inflection
New Projects/Investments
- Alignment Healthcare has achieved significant growth, reaching over 275,000 members and guiding to nearly 300,000 by year-end, with premium revenue approaching $4 billion and a 30% annual growth rate over the last decade.
- The company's care management model enables strong growth while improving Medical Loss Ratios (MLR), demonstrated by 58% growth in 2024 and 31% growth in Q1 2025, where MLR decreased. All members are in four-star and above plans, including three five-star plans.
- Alignment Healthcare is expanding geographically, with 84% growth outside California, where gross profit per member per month (PMPM), Star Ratings, and utilization management metrics are better. The company plans to invest in new markets starting in 2027.
- The company reaffirmed its 2025 guidance for mid-to-high 90s MLR and expects $145 million in Adjusted EBITDA for 2026. Management anticipates continued growth and margin expansion, projecting $7 billion to $8 billion in revenue within three years.
Jan 14, 2026, 6:30 PM
Alignment HealthCare Reports Strong Membership Growth and Profitability Outlook
ALHC
Revenue Acceleration/Inflection
Guidance Update
New Projects/Investments
- Alignment HealthCare reported 275,300 total members as of Jan. 1, 2026, reflecting 31% year-over-year growth from 209,900 members on Jan. 1, 2025. The company provides a year-end 2026 membership guidance range of 290,000 to 296,000.
- The company projects a profitability inflection in 2025 with an adjusted EBITDA guidance raised to $94 million at the midpoint, and expects consensus adjusted EBITDA of $145 million for FY 2026. Total revenue is projected at $3,939 million for both 2025G and 2026G.
- 100% of Alignment's members are in plans rated 4 stars or above for the 2025 and 2026 payment years, supported by a 19% improvement in voluntary disenrollment from 7.9% in 2025 to 6.4% in 2026.
- ALHC plans to invest in new market infrastructure in 2026 and launch new markets in 2027, leveraging internally generated cash flows to expand its footprint beyond its current 275,300 members across 45 counties and 5 states.
Jan 14, 2026, 6:30 PM
Alignment Healthcare Discusses Growth, Strategy, and Future Outlook at J.P. Morgan Healthcare Conference
ALHC
Guidance Update
New Projects/Investments
Revenue Acceleration/Inflection
- Alignment Healthcare reported robust growth, with over 275,000 members and guided to nearly 300,000 by year-end, approaching $4 billion in premium revenue on a guidance basis, and consistently growing at 30% per year. The company achieved 58% growth in 2024 and 31% in Q1 (through Q3 data).
- The company attributes its performance to a care management model that stratifies members and deploys "Care Anywhere" teams, resulting in improved retention and 80% of growth from switchers. This model also leads to better gross profit PMPMs and Star Ratings outside of California.
- The CFO reaffirmed 2025 guidance (mid-to-high 90s, mid-2s margin) and provided preliminary 2026 guidance of $145 million in Adjusted EBITDA. Management projects $7 billion to $8 billion in revenue within three years (assuming 20% annual growth) and plans to invest in new markets starting in 2027.
Jan 14, 2026, 6:30 PM
Quarterly earnings call transcripts for Alignment Healthcare.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more